New Patient Map Underscores How Drug Pricing Crisis Hurts Everyday Americans
In sharing thousands of new stories in 2019, patients show they are ready to mobilize to push for reforms.
Reaction to White House Blog Post on H.R. 3
Council of Economic Advisers analysis puts politics over patients.
Patients Don’t Buy Big Pharma’s Lies
Read what independent experts are saying about H.R. 3, a bill to lower drug prices.
STAT OP-ED: Letting academic medical centers make CAR-T drugs would save billions
High prices not only pose a challenge to patient access, but they also raise a fundamental question: Are we creating these therapies the wrong way?
NEW REPORT: The Truth About Insulin Prices
On World Diabetes Day, Patients Demand Action To Address The Insulin Pricing Crisis.
